The Global Optical Genome Mapping Market Size accounted for USD 108.3 Million in 2023 and is estimated to achieve a market size of USD 772.7 Million by 2032 growing at a CAGR of 24.9% from 2024 to 2032.

Optical Genome Mapping Market Highlights

• Global optical genome mapping market revenue is poised to garner USD 772.7 million by 2032 with a CAGR of 24.9% from 2024 to 2032
• North America optical genome mapping market value occupied around USD 46.6 million in 2023
• Asia-Pacific optical genome mapping market growth will record a CAGR of more than 25.5% from 2024 to 2032
• Among product, the software and services sub-segment generated 39% of the market share in 2023
• Based on solution, the structural variant detection sub-segment generated around 48% market share in 2023
• Growing technological advancements is a optical genome mapping market trend that fuels the industry demand

Optical genome mapping it’s a molecular biological technique to provide high resolution map of entire genome. It involves the use of high-resolution imaging to map the physical location of DNA molecules within a genome. Applications of optical genome mapping include identifying large-scale genomic rearrangements, such as insertions, deletions, and inversions, which are crucial for understanding genetic diseases, cancer development, and evolutionary processes. OGM also aids in genome assembly and, assisting in the construction of high-quality reference genomes for various organisms. Additionally, it can be used for studying epigenetic modifications and chromatin structure, further expanding its utility in elucidating genome function and regulation. Overall, optical genome mapping offers a versatile approach for comprehensive genomic analysis with wide-ranging applications in research, diagnostics, and biotechnology.

Global Optical Genome Mapping Market Dynamics

Market Drivers

• Increasing demand for personalized medicine
• Accurate detection of structural variation
• Growing bio-pharmaceuticals advancements in drug development

Market Restraints

• High cost of instruments and services
• Privacy concerns and regulatory hurdles
• Data analysis complexity

Market Opportunities

• Advancements in optical mapping technology
• Genomic research initiatives
• Government initiatives in the genome mapping for innovative developments

Optical Genome Mapping Market Report Coverage

Optical Genome Mapping Market Insights

The optical genome mapping market is growing significantly due to to increasing demand for personalized medicines in the forecast year. This growth is attributed to the rising number of cancer cases and other harmful diseases worldwide. Hence, robust key players focus on new inventions and collaborations to make a positive impact on this market. For instance, to execute precision medicine in healthcare for strategic content-specific efforts, Genomic Medicine Sweden (GMS) collaborated with the Centre for Personalized Medicine in Germany (ZPM) in February 2022. Additionally, accurate detection of structural variation and government initiatives in genome mapping for innovative developments drive the growth of the optical genome mapping market in the coming years.

However, the high cost of instruments and services impedes the growth of the market. The initial cost of instruments and services might be prohibitively costly to biotechnology enterprises with smaller startups, academic institutes, and clinical laboratories. Obstacles related to maintenance, consumable fees, and technical support become major cost-related factors. As a result, these budget-related concerns may prevent the business from choosing optical genome mapping and hamper growth. Moreover, privacy concerns regulatory hurdles and data analysis complexity hamper the market’s growth. Genomic information is provided by optical genome mapping thus there is concern created regarding patient’s data privacy. To protect the patient’s genomic data there is a need to develop trust issues in this technology which leads to become a restrain for this market.

Advancements in optical mapping technology create an opportunity for the optical genome mapping market in the forecast period 2024 to 2032. Technical advancements such as improvement in accuracy, scalability, and speed contribute to the market expansion. Furthermore, key players are engaged in the formation of new techniques to develop strength in sample research. For instance, for optical genome mapping workflow, Bionano Genomics, Inc. launched numerous products and advancements in January 2023. Besides, genomic research initiatives and government initiatives in genome mapping for innovative developments further become an opportunity for the market.

Optical Genome Mapping Market Segmentation

The worldwide market for optical genome mapping is split based on product, solution, application, end-users, and geography.

Optical Genome Mapping Product

• Instruments
• Consumables and Reagents
• Software and Services

According to the optical genome mapping industry analysis, software and services dominate the market. Software and services provide important accomplishment, formulation, and OGM data analysis in the form of records that can be stored. Additionally, software and services offer diverse solutions to gather the clinical or research requirements. To present accurate readings and results there is a use of customized services which include interprtations and data processing throughout optical genome mapping. In addition to this software and services assist annotation, data visualization, and structural variation analysis. As a result, these facilities propel the demand for software and services in the optical genome mapping market.

Optical Genome Mapping Solution

• Structural Variant Detection
• Genome Assembly
• Microbial Strain Typing
• Others

The structural variant detection category leads the optical genome mapping market. Structural variant detection offers diverse applications in the identification of genetic disorders such as cancer or inherited diseases. Additionally, structural variant detection plays a crucial role in the correct diagnosis and prognosis in clinical diagnostics. Therefore, the identification of chromosomal rearrangements and somatic variations leads to expected patient outcomes, differentiates cancer subtypes, and guides targeted therapies. Overall, the OGM is used in various research and diagnostics applications.

Optical Genome Mapping Application

• Research
• Diagnostics

According to the optical genome mapping forecast, the research segment is expected to dominate the optical genome mapping market. To gain insights into disease mechanisms researchers are vastly utilizing this technology. OGM presents a vital role in the identification of genetic abnormalities regarding numerous diseases, genomic rearrangements, and structural variations. Additionally, growing educational initiatives and training programs related to the advantages of optical genome mapping further boost the researcher segment growth in the forecast year.

Optical Genome Mapping End-Users

• Biotechnology and Pharmaceutical Companies
• Clinical Laboratories
• Academic research institutes
• Others

By application, the biotechnology and pharmaceutical companies segment registered the maximum share in 2023 and is projected to maintain its dominance over the estimated period from 2024 to 2032. For instance, to focus on the importance of OGM technology, the annual clinical genetics gathering at Columbia University Medical Center (CUMC) on April 2021 has been organized at the American College of Medical Genetics and Genomics. Biotechnology and phramaceuticals segmnet is crucial in the optical genome mapping market. Commitment by biotechnology and pharamaceutical companies to improving genome technology further improve its dominance in the OGM market. Pharmaceutical companies utilizes this genome mapping for the variety of purposes such as drug development, biomarker identification, and precision medicine.

Optical Genome Mapping Market Regional Outlook

North America

• U.S.
• Canada

Europe

• U.K.
• Germany
• France
• Spain
• Rest of Europe

Asia-Pacific

• India
• Japan
• China
• Australia
• South Korea
• Rest of Asia-Pacific

Latin America

• Brazil
• Mexico
• Rest of LATAM

The Middle East & Africa

• South Africa
• GCC Countries
• Rest of the Middle East & Africa (ME&A)

Optical Genome Mapping Market Regional Analysis

In terms of optical genome mapping market analysis, North America dominates the optical genome mapping (OGM) market. This growth is attributed to several factors. The region's robust healthcare infrastructure and technological advancements in genomics contribute to the robust growth. For instance, to create and maintain a human genome reference sequence USD 29.5 million was invested by the National Institute of Health in September 2019. Additionally, the growing demand for personalized medicine among consumers in the countries like U.S., Canada, and Mexico is spurred. The development in drug discovery raised the optical genome mapping market demand in the North American region. Furthermore, growing investments in genomics and the region's strong healthcare infrastructure maintain North America’s dominance in the market. As a result, the presence of major research institutes and biotechnological companies makes this region a frontrunner in the optical genome mapping market.

Asia-Pacific is the fastest-growing region in the optical genome mapping market. Asia-Pacific region contains a strong emphasis on innovations and scientific research and developments. Moreover, advancements in optical genome mapping techniques further contribute to the market’s fastest growth in this region. For instance, Nucleome Informatics Private Limited announced the acquisition of South Asia’s first PacBio Sequel II system in September 2020. Government initiatives in genome mapping for innovative developments further propel the demand for OGM in the Asia-Pacific region. Besides, the robust healthcare infrastructure and the presence of prominent key players due to their research and development activities Asia-Pacific is the fastest-growing region in this market. As a result, countries like China, India, Japan, Australia, and South Africa focus on genomic research leading to evaluations of genomic-based solutions for various diseases.

Optical Genome Mapping Market Players

Some of the top optical genome mapping companies offered in our report includes Cerba HealthCare, Bionano Genomics, Hofkens Lab, Nucleome Informatics Private Limited, Genohub Inc, Praxis Genomics, LLC, PerkinElmer (PerkinElmer Genomics), SourceBio International Limited (Source BioScience), INRAE (French Plant Genomic Resources Center (CNRGV)) and OpGen, Inc.

TABLE OF CONTENT